![]() |
Volumn 20, Issue 22, 2001, Pages 6404-6413
|
hADA3 is required for p53 activity
a
a
b
a
a
b
a
|
Author keywords
Apoptosis; DNA damage; hADA3; Histone acetyltransferase; p53
|
Indexed keywords
HISTONE ACETYLTRANSFERASE;
PROTEIN HADA3;
PROTEIN P53;
UNCLASSIFIED DRUG;
AMINO TERMINAL SEQUENCE;
APOPTOSIS;
ARTICLE;
CONTROLLED STUDY;
DNA DAMAGE;
GENE ACTIVITY;
GENE MUTATION;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
MITOSIS INHIBITION;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
PROTEIN PROCESSING;
PROTEIN PROTEIN INTERACTION;
PROTEIN STABILITY;
ACETYLTRANSFERASES;
ANTIBIOTICS, ANTINEOPLASTIC;
APOPTOSIS;
CELL LINE;
CELLS, CULTURED;
DNA;
DNA DAMAGE;
DNA, COMPLEMENTARY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
FLOW CYTOMETRY;
GENE LIBRARY;
GENES, P53;
GENES, REPORTER;
HELA CELLS;
HISTONE ACETYLTRANSFERASES;
HUMANS;
MODELS, BIOLOGICAL;
MUTATION;
OLIGONUCLEOTIDES, ANTISENSE;
PHOSPHORYLATION;
PLASMIDS;
PRECIPITIN TESTS;
PROTEIN BINDING;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
SACCHAROMYCES CEREVISIAE;
SACCHAROMYCES CEREVISIAE PROTEINS;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
TRANSFECTION;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
ULTRAVIOLET RAYS;
|
EID: 0035890271
PISSN: 02614189
EISSN: None
Source Type: Journal
DOI: 10.1093/emboj/20.22.6404 Document Type: Article |
Times cited : (74)
|
References (47)
|